Form 4 Tracker
Jeffrey W Sherman

Director · 1 filing · Latest: Feb 27, 2026

Larimar Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LRMR
Jeffrey W ShermanDirectorFeb 27, 2026
Purchase
$5.005,000$25.0K5,000
XERS
JEFFREY SHERMANAug 28, 2025
Proposed Sale
$7.9242,232$334.5K